Soligenix, Inc.

Get Full Access

Description

  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a novel photodynamic therapy, which has completed Phase III clinical trial to treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial to treat oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate, which has completed Phase I/II clinical trial for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease and SGX201 for acute radiation enteritis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a melioidosis therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.
  • location

    Headquarters:29 Emmons Drive Suite B, Princeton, New Jersey, United States

    More
  • Soligenix, Inc. phone

    Phone Number: +1 609-538-8200

  • Soligenix, Inc. website

    Website: https://www.soligenix.com

  • Soligenix, Inc. employees

    Employees:23

  • Soligenix, Inc. revenue

    Revenue:$1 - 10M

  • Soligenix, Inc. legal name

    Legal Name:Soligenix, Inc.

  • Soligenix, Inc.'s Social Media

    Soligenix, Inc. linkedin Soligenix, Inc. facebook Soligenix, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 541715  |

      NYSE: SNGX

    Show More
Person level website identification

Chief Scientific Officer for Soligenix, Inc.

Robert Brey

Chief Scientific Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Robert Brey

Chief Scientific Officer

Oreola Donini

Chief Scientific Officer

Richard Straube

Chief Medical Officer

Adam Rumage

Vice President, Project Management And Regulatory Affairs At Soligenix, Inc

Ralph Cavalli

Vice President Biopharmaceutical Development

Frequently Asked Questions regarding Soligenix, Inc.

  • Where are Soligenix, Inc.'s Headquarters?

    Soligenix, Inc.'s Headquarters are in 29 Emmons Drive Suite B,Princeton,New Jersey,United States

  • What is Soligenix, Inc.'s phone number?

    Soligenix, Inc.'s phone number is +1 609-538-8200

  • What is Soligenix, Inc.'s stock symbol?

    Soligenix, Inc.'s stock symbol is SNGX

  • What is Soligenix, Inc.'s official website?

    Soligenix, Inc.'s official website is https://www.soligenix.com

  • What is Soligenix, Inc.'s Revenue?

    Soligenix, Inc.'s revenue is $1 - 10M

  • What is Soligenix, Inc.'s NAICS code?

    Soligenix, Inc.'s NAICS code is 541715

  • How many employees are working in Soligenix, Inc.

    Soligenix, Inc. has 23 employees

  • What is Soligenix, Inc.'s Industry?

    Soligenix, Inc. is in the industry of Biotechnology

Company Directory